Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4642091
Max Phase: Preclinical
Molecular Formula: C30H37Cl2F3N6O4S
Molecular Weight: 632.71
Molecule Type: Unknown
Associated Items:
ID: ALA4642091
Max Phase: Preclinical
Molecular Formula: C30H37Cl2F3N6O4S
Molecular Weight: 632.71
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCC[C@@H]1CCCN1Cc1sc(NC(=O)c2cnc(N3CCC(C(=O)O)CC3)cn2)nc1-c1ccc(OC)c(C(F)(F)F)c1.Cl.Cl
Standard InChI: InChI=1S/C30H35F3N6O4S.2ClH/c1-3-5-20-6-4-11-39(20)17-24-26(19-7-8-23(43-2)21(14-19)30(31,32)33)36-29(44-24)37-27(40)22-15-35-25(16-34-22)38-12-9-18(10-13-38)28(41)42;;/h7-8,14-16,18,20H,3-6,9-13,17H2,1-2H3,(H,41,42)(H,36,37,40);2*1H/t20-;;/m1../s1
Standard InChI Key: MDDKPVSOOMAKPO-FAVHNTAZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 632.71 | Molecular Weight (Monoisotopic): 632.2393 | AlogP: 5.95 | #Rotatable Bonds: 10 |
Polar Surface Area: 120.78 | Molecular Species: ZWITTERION | HBA: 9 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 10 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 3.24 | CX Basic pKa: 8.87 | CX LogP: 3.02 | CX LogD: 3.01 |
Aromatic Rings: 3 | Heavy Atoms: 44 | QED Weighted: 0.28 | Np Likeness Score: -1.50 |
1. Tanaka H, Negoro K, Koike T, Tsukamoto I, Yokoyama K, Maeda J, Inagaki Y, Shimoshige Y, Ino K, Ishizu K, Takahashi T.. (2020) Discovery and structure-activity relationships study of positive allosteric modulators of the M3 muscarinic acetylcholine receptor., 28 (13): [PMID:32386953] [10.1016/j.bmc.2020.115531] |
Source(1):